MUMBAI India — Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (U.S. FDA) for clindamycin phosphate gel USP, 1%, the generic version of Cleocin T1 Gel, 1%, of Pharmacia & Upjohn.

According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T Gel, 1% market2 achieved annual sales of approximately $73.8 million.